[Participation is the foundation of successful treatment of psychotic disorders].

Lakartidningen

Karolinska Institutet - Clinical Neurosciences Stockholm, Sweden KI - Clinical neuroscience Stockholm, Sweden.

Published: October 2015

Schizophrenia is among the most severe psychiatric disorders, but due to extensive research we now have evidence-based interventions that may enable these patients to live a fairly normal life.  Every decision regarding the choice of intervention or treatment should be made according to a shared decision making, meaning that the patient and Case Manager are equal parties and equally responsible for the choice. The individual coordinated care plan prepared in agreement by the patient and Case Manager should be the governing principle for the rehabilitation process. Antipsychotic medication is a prerequisite for any rehabilitation but should typically be combined with psychosocial intervention for an optimal outcome. In order to properly judge treatment response, symptom ratings should be combined with global ratings to take into account aspects that are not accounted for in symptom rating scales. If the effect of an antipsychotic medication is inadequate, a psychosocial intervention may be considered as an alternative to increasing the dosage or adding another antipsychotic medication to minimize side effects. One of the most important rehabilitating interventions is supported employment with individual placement and support.

Download full-text PDF

Source

Publication Analysis

Top Keywords

antipsychotic medication
12
patient case
8
case manager
8
psychosocial intervention
8
[participation foundation
4
foundation successful
4
successful treatment
4
treatment psychotic
4
psychotic disorders]
4
disorders] schizophrenia
4

Similar Publications

Autism spectrum disorder (ASD) is linked to ion channel dysfunction, including chloride voltage-gated channel-4 (CLCN4). We generated Clcn4 knockout (KO) mice by deleting exon 5 of chromosome 7 in the C57BL/6 mice. Clcn4 KO exhibited reduced social interaction and increased repetitive behaviors assessed using three-chamber and marble burying tests.

View Article and Find Full Text PDF

Objectives: To explore the factors influencing medication adherence and the medication needs of patients with schizophrenia when living in a community in China.

Design: A qualitative study.

Setting: Community and psychiatric ward in Zhuhai city, Guangdong province.

View Article and Find Full Text PDF

Study Objectives: This study assessed the utilization of potentially inappropriate medications (PIM) including oral sedative-hypnotic and atypical antipsychotic (OSHAA), healthcare resource utilization (HCRU), and costs among elderly individuals with insomnia and in the subpopulation with Alzheimer's Disease (AD) who also had a diagnosis of insomnia.

Methods: Using claims database containing International Classification of Diseases, 10th Revision (ICD-10) codes, the cohort included individuals aged ≥ 65 with incident insomnia (EI, N=152,969) and AD insomnia subpopulation (ADI, N=4,888). Proportion of patients utilizing atypical antipsychotics or oral sedative-hypnotic medications, namely z-drugs, benzodiazepines, doxepin, Dual Orexin Receptor Antagonists (DORAs), and melatonin agonists, were assessed.

View Article and Find Full Text PDF

Dual inhibition of cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) is a recognized strategy for enhanced anti-inflammatory effects in small molecules, offering potential therapeutic benefits for individuals at risk of dementia, particularly those with neurodegenerative diseases, common cancers, and diabetes type. Alzheimer's disease (AD) is the most common cause of dementia, and the inhibition of acetylcholinesterase (AChE) is a key approach in treating AD. Meanwhile, Caspase-3 catalyzes early events in apoptosis, contributing to neurodegeneration and subsequently AD.

View Article and Find Full Text PDF

The Role of Neuroglia in the Development and Progression of Schizophrenia.

Biomolecules

December 2024

Neurochemical Research Unit and Bebensee Schizophrenia Research Unit, Department of Psychiatry and Neuroscience and Mental Health Institute, University of Alberta, Edmonton, AB T6G 2G3, Canada.

Schizophrenia is a complex heterogenous disorder thought to be caused by interactions between genetic and environmental factors. The theories developed to explain the etiology of schizophrenia have focused largely on the dysfunction of neurotransmitters such as dopamine, serotonin and glutamate with their receptors, although research in the past several decades has indicated strongly that other factors are also involved and that the role of neuroglial cells in psychotic disorders including schizophrenia should be given more attention. Although glia were originally thought to be present in the brain only to support neurons in a physical, metabolic and nutritional capacity, it has become apparent that these cells have a variety of important physiological roles and that abnormalities in their function may make significant contributions to the symptoms of schizophrenia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!